Empagliflozin vs Gefitinib

## Empagliflozin vs Gefitinib: Overview

This comparison examines the pharmacological differences between **Empagliflozin** and **Gefitinib**.

## Mechanism of Action

**Empagliflozin**: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

**Gefitinib**: Selective reversible inhibitor of EGFR tyrosine kinase.

## Pharmacokinetics

**Half-life**: Empagliflozin — 12.4 hours; Gefitinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Empagliflozin — C23H27ClO7; Gefitinib — C22H24ClFN4O3.

**Molecular Weight**: Empagliflozin — 450.9100 g/mol; Gefitinib — 446.9000 g/mol.

**Type**: Empagliflozin — Small molecule; Gefitinib — Small molecule.